Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Vγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates.

Li J, Li H, Mao H, Yu M, Feng T, Yang F, Fan Y, Lu Q, Shen C, Yin Z, Tu W, Mao M.

Cell Mol Immunol. 2013 May;10(3):253-60. doi: 10.1038/cmi.2012.78. Epub 2013 Mar 25.


Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates.

Li J, Li H, Mao H, Yu M, Yang F, Feng T, Fan Y, Lu Q, Shen C, Yin Z, Mao M, Tu W.

Cell Mol Immunol. 2013 Sep;10(5):437-43. doi: 10.1038/cmi.2013.31. Epub 2013 Jul 22.


In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.

Poccia F, Malkovsky M, Pollak A, Colizzi V, Sireci G, Salerno A, Dieli F.

Mol Med. 1999 Jul;5(7):471-6.


Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses.

Qin G, Mao H, Zheng J, Sia SF, Liu Y, Chan PL, Lam KT, Peiris JS, Lau YL, Tu W.

J Infect Dis. 2009 Sep 15;200(6):858-65. doi: 10.1086/605413.


Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes.

Poccia F, Gougeon ML, Agrati C, Montesano C, Martini F, Pauza CD, Fisch P, Wallace M, Malkovsky M.

Curr Mol Med. 2002 Dec;2(8):769-81. Review.


High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.

Benzaïd I, Mönkkönen H, Stresing V, Bonnelye E, Green J, Mönkkönen J, Touraine JL, Clézardin P.

Cancer Res. 2011 Jul 1;71(13):4562-72. doi: 10.1158/0008-5472.CAN-10-3862. Epub 2011 Jun 6.


Serum IgG at birth in preterm appropriate- and small-for-gestational age newborns.

Sharma M, Laroia D, Taluja RK, Mathur PS.

Indian J Pediatr. 1991 Sep-Oct;58(5):657-60.


Type 1 responses of human Vγ9Vδ2 T cells to influenza A viruses.

Qin G, Liu Y, Zheng J, Ng IH, Xiang Z, Lam KT, Mao H, Li H, Peiris JS, Lau YL, Tu W.

J Virol. 2011 Oct;85(19):10109-16. doi: 10.1128/JVI.05341-11. Epub 2011 Jul 13.


Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.

Cabillic F, Toutirais O, Lavoué V, de La Pintière CT, Daniel P, Rioux-Leclerc N, Turlin B, Mönkkönen H, Mönkkönen J, Boudjema K, Catros V, Bouet-Toussaint F.

Cancer Immunol Immunother. 2010 Nov;59(11):1611-9. doi: 10.1007/s00262-010-0887-0. Epub 2010 Jun 26.


Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells.

Dunne MR, Mangan BA, Madrigal-Estebas L, Doherty DG.

Mediators Inflamm. 2010;2010:704941. doi: 10.1155/2010/704941. Epub 2011 Feb 21.


In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.

Benzaïd I, Mönkkönen H, Bonnelye E, Mönkkönen J, Clézardin P.

Clin Cancer Res. 2012 Nov 15;18(22):6249-59. doi: 10.1158/1078-0432.CCR-12-0918. Epub 2012 Oct 2.


Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults.

Gasparoni A, Ciardelli L, Avanzini A, Castellazzi AM, Carini R, Rondini G, Chirico G.

Biol Neonate. 2003;84(4):297-303.


Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.

Vantourout P, Mookerjee-Basu J, Rolland C, Pont F, Martin H, Davrinche C, Martinez LO, Perret B, Collet X, Périgaud C, Peyrottes S, Champagne E.

J Immunol. 2009 Sep 15;183(6):3848-57. doi: 10.4049/jimmunol.0901085. Epub 2009 Aug 26.


Neonatal pattern of adrenergic metabolites in urine of small for gestational age and preterm infants.

Dalmaz Y, Peyrin L, Dutruge J, Sann L.

J Neural Transm. 1980;49(3):151-65.


Immunoglobulins IgG, IgM and IgA levels in preterm and small for date newborns.

Sharma S, Lal H, Saigal RK.

Indian Pediatr. 1991 Jul;28(7):741-4.


Neonates harbour highly active gammadelta T cells with selective impairments in preterm infants.

Gibbons DL, Haque SF, Silberzahn T, Hamilton K, Langford C, Ellis P, Carr R, Hayday AC.

Eur J Immunol. 2009 Jul;39(7):1794-806. doi: 10.1002/eji.200939222.


Comparison study between induced and spontaneous term and preterm births of small-for-gestational-age neonates.

Hershkovitz R, Erez O, Sheiner E, Bashiri A, Furman B, Shoham-Vardi I, Mazor M.

Eur J Obstet Gynecol Reprod Biol. 2001 Aug;97(2):141-6.


Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

Gougeon ML, Malkovsky M, Casetti R, Agrati C, Poccia F.

Vaccine. 2002 May 6;20(15):1938-41. Review.

Items per page

Supplemental Content

Write to the Help Desk